Endocrine Disorders with Parathyroid Hormone-Independent Hypercalcemia.

[1]  E. Webber,et al.  Perioperative Hypotensive Crisis in an Adolescent with a Pancreatic VIPoma and MEN1-Gene Variant , 2018, Hormone Research in Paediatrics.

[2]  M. Horwitz.  Non‐Parathyroid Hypercalcemia , 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

[3]  V. Viswanathan,et al.  Infants With Congenital Adrenal Hyperplasia Are at Risk for Hypercalcemia, Hypercalciuria, and Nephrocalcinosis , 2017, Journal of the Endocrine Society.

[4]  P. Vestergaard,et al.  MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - a systematic review and meta-analysis. , 2017, European journal of endocrinology.

[5]  H. Randeva,et al.  Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours. , 2016, Endocrine-related cancer.

[6]  H. Yoon,et al.  Adrenal insufficiency presenting as hypercalcemia and acute kidney injury , 2016, International medical case reports journal.

[7]  M. Brandi,et al.  Ventricular fibrillation resulting from electrolyte imbalance reveals vipoma in MEN1 syndrome , 2016, Familial Cancer.

[8]  M. Fernando,et al.  Phaeochromocytoma with hypercortisolism and hypercalcaemia , 2015, BMJ Case Reports.

[9]  J. Snell-Bergeon,et al.  Type 1 diabetes and risk of fracture: meta‐analysis and review of the literature , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[10]  D. McLeod,et al.  PTHrP-mediated hypercalcemia: causes and survival in 138 patients. , 2015, The Journal of clinical endocrinology and metabolism.

[11]  I. Floriani,et al.  Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. , 2015, The Journal of clinical endocrinology and metabolism.

[12]  M. Brandi,et al.  Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[13]  A. Tyroch,et al.  Relative Adrenal Insufficiency in the Critical Care Setting: Debunking the Classic Myth , 2011, World Journal of Surgery.

[14]  L. Ceriani,et al.  Evaluation of serum parathyroid hormone‐related peptide in hyperthyroid patients , 2011, European journal of clinical investigation.

[15]  U. Lerner,et al.  Osteotropic effects by the neuropeptides calcitonin gene-related peptide, substance P and vasoactive intestinal peptide. , 2008, Journal of musculoskeletal & neuronal interactions.

[16]  J. Cameron,et al.  Pancreatic VIPomas: Subject Review and One Institutional Experience , 2008, Journal of Gastrointestinal Surgery.

[17]  R. Bouillon,et al.  Etiology of hypercalcemia in a patient with Addison's disease , 2006, Calcified Tissue International.

[18]  F. Ritzl,et al.  Hypercalcemia in hyperthyroidism role of age and goiter type , 1981, Klinische Wochenschrift.

[19]  Stuart M Lubinski,et al.  Images in clinical medicine. VIPoma. , 2004, The New England journal of medicine.

[20]  J. Kanis,et al.  Diagnosis of osteoporosis and assessment of fracture risk , 2002, The Lancet.

[21]  A. Scillitani,et al.  Gender Differences in Serum Markers of Bone Resorption in Healthy Subjects and Patients with Disorders Affecting Bone , 2002, Osteoporosis International.

[22]  John P. Bilezikian,et al.  CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2 , 2001 .

[23]  R. Dash,et al.  Effect of growth hormone therapy in burn patients on conservative treatment. , 1998, Burns : journal of the International Society for Burn Injuries.

[24]  J. K. Martin,et al.  Vasoactive intestinal polypeptide secreting islet cell tumors: a 15-year experience and review of the literature. , 1998, Surgery.

[25]  R. Bouillon,et al.  Effects of short‐term insulin‐like growth factor‐I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man , 1997, Journal of internal medicine.

[26]  C. Kovacs,et al.  Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. , 1995, The Journal of clinical endocrinology and metabolism.

[27]  D. Wilmore,et al.  Hypercalcemia associated with the use of human growth hormone in an adult surgical intensive care unit. , 1995, Archives of surgery.

[28]  S. Melmed,et al.  Biochemical assessment of bone formation and resorption in acromegaly. , 1993, The Journal of clinical endocrinology and metabolism.

[29]  G. Colussi,et al.  Hypercalcemia in Addison's disease: calciotropic hormone profile and bone histology , 1992, Journal of internal medicine.

[30]  R. MacIsaac,et al.  Parathyroid hormone‐related protein: a possible endocrine function in lactation , 1992, Clinical endocrinology.

[31]  M. Kathol,et al.  A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. , 1992, The Journal of clinical endocrinology and metabolism.

[32]  S. Lamberts,et al.  The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition , 1992, Clinical endocrinology.

[33]  F. Lafferty,et al.  Differential diagnosis of hypercalcemia , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[34]  K. Shimada,et al.  A case of pheochromocytoma producing parathyroid hormone-related protein and presenting with hypercalcemia. , 1990, The Journal of clinical endocrinology and metabolism.

[35]  L. Raisz,et al.  Glucocorticoid-induced osteoporosis: pathogenesis and management. , 1990, Annals of internal medicine.

[36]  L. Lind,et al.  Hypercalcemia in pulmonary tuberculosis. , 1990, Upsala journal of medical sciences.

[37]  D. Diep,et al.  High levels of a parathyroid hormone-like protein in milk. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. A. Jensen,et al.  Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease. , 1988, Scandinavian journal of clinical and laboratory investigation.

[39]  S. Corsello,et al.  A Clinical Study of Addison's Disease , 1932, Experimental and clinical endocrinology.

[40]  A. Fournier,et al.  Effect of thyrotoxicosis and its treatment on mineral and bone metabolism , 1986, Journal of endocrinological investigation.

[41]  A. F. Stewart,et al.  Hypercalcemia in pheochromocytoma. Evidence for a novel mechanism. , 1985, Annals of internal medicine.

[42]  R. Bosch,et al.  Changes in bone metabolism during treatment of acromegaly. , 1983, Acta endocrinologica.

[43]  R. Greenwood,et al.  SERUM CALCIUM CONCENTRATION IN HYPERTHYROIDISM AT DIAGNOSIS AND AFTER TREATMENT , 1983, Clinical endocrinology.

[44]  L. Mosekilde,et al.  Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism. , 1982, Metabolism: clinical and experimental.

[45]  B. Fairhurst,et al.  Hypercalcaemia and phaeochromocytoma. , 1981, Postgraduate medical journal.

[46]  A. Norman,et al.  Calcium and vitamin D metabolism in acromegaly. , 1981, Acta endocrinologica.

[47]  L. Mosekilde,et al.  Morphometric and Dynamic Studies of Bone Changes in Hypothyroidism , 1978, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[48]  F. Melsen,et al.  Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: Bone histomorphometry. , 1978, Acta endocrinologica.

[49]  L. Mosekilde,et al.  Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. , 1977, Acta endocrinologica.

[50]  L. Mosekilde,et al.  Decreased parathyroid function in hyperthyroidism: interrelationships between serum parathyroid hormone, calcium-phosphorus metabolism and thyroid function. , 1977, Acta endocrinologica.

[51]  K. Hellström,et al.  Prevalence of hypercalcaemia in a health screening in Stockholm. , 2009, Acta medica Scandinavica.

[52]  J. Woodhead,et al.  Phaeochromocytoma and hypercalcaemia , 1976, Postgraduate medical journal.

[53]  J. Earll,et al.  Ionized and total serum calcium and parathyroid hormone in hyperthyroidism. , 1976, Annals of internal medicine.

[54]  J. Casey,et al.  Hypercalcaemia and Multiple Pheochrcmocytomas , 1975 .

[55]  S. Sheps,et al.  Parathyroid function in patients with pheochromocytoma. , 1975, Annals of internal medicine.

[56]  R. Askenasi,et al.  Urinary excretion of hydroxylysyl glycosides and thyroid function. , 1975, The Journal of clinical endocrinology and metabolism.

[57]  C. Martinez,et al.  The serum calcium level and its significance in hyperthyroidism: a prospective study , 1974, The American journal of the medical sciences.

[58]  J. Nerup.  ADDISON'S DISEASE – CLINICAL STUDIES. A REPORT OF 108 CASES , 1974 .

[59]  H. Jørgensen.  Hypercalcemia in adrenocortical insufficiency. , 2009, Acta medica Scandinavica.

[60]  S. Kukreja,et al.  Pheochromocytoma causing excessive parathyroid hormone production and hypercalcemia. , 1973, Annals of internal medicine.

[61]  N. Swinton,et al.  Hypercalcemia and familial pheochromocytoma. Correction after adrenalectomy. , 1972, Annals of internal medicine.

[62]  V. Marks,et al.  Plasma levels of ionised calcium and magnesium in thyroid disease. , 1967, Lancet.

[63]  J. Baxter,et al.  Hypercalcemia of thyrotoxicosis. , 1966, Annals of internal medicine.

[64]  J. Duckett,et al.  The hypercalcemia of adrenal insufficiency. , 1963, The Journal of clinical investigation.

[65]  C. E. Lowe,et al.  Hypercalcemia in myxedema. , 1962, The Journal of clinical endocrinology and metabolism.

[66]  C. H. Leeksma,et al.  Hypercalcaemia in adrenal insufficiency. , 2009, Acta medica Scandinavica.